GHRP-6
Growth Hormone Releasing Peptide-6, Growth hormone-releasing hexapeptide, His-D-Trp-Ala-Trp-D-Phe-Lys-NH2
Positional scanning for peptide secondary structure by systematic solid-phase synthesis of amino lactam peptides.
Jamieson. Andrew G AG; Boutard. Nicolas N; Beauregard. Kim K; Bodas. Mandar S MS; Ong. Huy H; Quiniou. Christiane C; Chemtob. Sylvain S; Lubell. William D WD
Key Findings
- A new solid‑phase synthesis method efficiently adds alpha‑ and beta‑amino gamma‑lactams to peptides.
- Applied to GHRP‑6, the method produced 16 lactam‑constrained analogues.
- Several GHRP‑6 lactam analogues showed similar or improved binding to the GHS‑R1a and CD36 receptors compared with the unmodified peptide.
Practical Outcomes
- For biohackers, this work suggests that chemically locking GHRP‑6 into a specific shape could make more stable or potent versions, but creating these analogues requires specialized lab equipment and expertise. At present, the study doesn’t provide new dosing guidelines or ready‑to‑use formulations, but it points to future possibilities for improved peptide drugs.
Summary
Scientists developed a solid‑phase chemistry trick to lock parts of a peptide into a specific shape using tiny ring structures called lactams. They used this trick on the popular growth‑hormone‑releasing peptide GHRP‑6 and made 16 new versions. Some of these new versions bound the same receptors as the original peptide just as well or even better, showing the method can fine‑tune peptide activity.
Abstract
Incorporation of amino lactams into biologically active peptides has been commonly used to restrict conformational mobility, enhance selectivity, and increase potency. A solid-phase method using a Fmoc-protection strategy has been developed for the systematic synthesis of peptides containing configurationally defined alpha- and beta-amino gamma-lactams. N-Alkylation of N-silyl peptides with five- and six-member cyclic sulfamidates 9 and 8 minimized bis-alkylation and provided N-alkyl peptides, which underwent lactam annulation under microwave heating. Employing this solid-phase protocol on the growth hormone secretagogue GHRP-6, as well as on the allosteric modulator of the IL-1 receptor 101.10, has furnished 16 lactam derivatives and validated the effectiveness of this approach on peptides bearing aliphatic, aromatic, branched, charged, and heteroatomic side chains. The binding affinity IC(50) values of the GHRP-6 lactam analogues on both the GHS-R1a and CD36 receptors are reported as well as inhibition of thymocyte proliferation measurements for the 101.10 lactam analogues. In these cases, lactam analogues were prepared exhibiting similar or improved properties compared with the parent peptide. Considering the potential for amino lactams to induce peptide turn conformations, the effective method described herein for their supported construction on growing peptides, and for the systematical amino lactam scan of peptides, has proven useful for the rapid identification of the secondary structure necessary for peptide biological activity.
Study Information
pubmed
2009
2009-06-10T00:00:00.000Z
10.1021/ja9010628
70
101